首页> 外国专利> SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE THIAZOLYL METHYL ESTER OF 5S-(5R*,8R*,10R*,11R*)-10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-1-2-1(1-METHYLETHYL)-4-THIAZOLYL-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID AND PREPARATION METHOD THEREOF

SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE THIAZOLYL METHYL ESTER OF 5S-(5R*,8R*,10R*,11R*)-10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-1-2-1(1-METHYLETHYL)-4-THIAZOLYL-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID AND PREPARATION METHOD THEREOF

机译:包含[5S-(5R *,8R *,10R *,11R *)]-10-羟基-2-甲基-5-(1-甲基乙基)-1- [2-1()的噻唑基甲基酯的固体药物组合物1-甲基)-4-噻唑基] -3,6-二氧杂-8,11-双(苯甲基)-2,4,7,12-四氮杂十三烷十三酸及其制备方法

摘要

The invention relates to a solid pharmaceutical composition comprising the thiazolyl methyl ester of [5S-(5R*,8R*,10R*,11R*)]-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-1(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid and to a compound that enables gastrointestinal fluid to penetrate to penetrate said composition, which is selected from the group containing silicates and silica oxide. The invention also relates to a method of preparing said composition, comprising a mixing step in which the solvent aggregation time and speed are strictly controlled.
机译:本发明涉及包含[5S-(5R *,8R *,10R *,11R *)]-10-羟基-2-甲基-5-(1-甲基乙基)-1-的噻唑基甲酯的固体药物组合物[2-1(1-甲基乙基)-4-噻唑基] -3,6-二氧杂-8,11-双(苯基甲基)-2,4,7,12-四氮杂can烷-13-油酸和能够胃肠液渗透以渗透所述组合物,所述组合物选自硅酸盐和二氧化硅。本发明还涉及制备所述组合物的方法,其包括混合步骤,其中严格控制溶剂的聚集时间和速度。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号